BMGL - רווח נקי למניה (EPS TTM) Basel Medical Group Ltd
Basel Medical Group (BMGL) operates a diversified clinic network that ensures a steady patient flow, as evidenced by the rolling annual net income per share illustrated in this chart by the GURU.Markets system. The -0.37 mark indicates the yield level of this aesthetic medicine leader, which attracts premium clients. The business relies on decentralized procurement in Asia, completely eliminating supply chain transport disruptions.
פילוחים אנליטיים ודוחות נתונים של חברת Basel Medical (BMGL)
To objectively assess the operational efficiency of Basel Medical Group (BMGL), investors must analyze the actual income per share. This rolling annual earnings per share normalizes net income by excluding the impact of share issuances on the final result. The stability of this trend confirms the financial resilience and margin of safety of the business. For Basel Medical Group (BMGL), this metric reflects billing efficiency and patient inflow across Southeast Asian clinics. Growth in this indicator correlates directly with the company's ability to attract top-tier physicians.
